NPI Details
DR. Diana Lozano, M.D. is an internal medicine in Harlingen, TX with 30 years of experience. The provider is a physician who provides long-term, comprehensive care in the office and the hospital, managing both common and complex illness of adolescents, adults and the elderly. Internists are trained in the diagnosis and treatment of cancer, infections and diseases affecting the heart, blood, kidneys, joints and digestive, respiratory and vascular systems. They are also trained in the essentials of primary care internal medicine, which incorporates an understanding of disease prevention, wellness, substance abuse, mental health and effective treatment of common problems of the eyes, ears, skin, nervous system and reproductive organs. DR. Diana Lozano, M.D. NPI is 1184620247. The provider is registered as an individual entity type.
The NPPES NPI record indicates the provider is a female.
Education
Medical School: INDIANA UNIVERSITY SCHOOL OF MEDICINE
Graduation Year:1996
The provider's business location address is:
5505 S EXPRESSWAY 77
STE 203
HARLINGEN, TX
ZIP 78550-222
Phone: (956) 440-2800
Fax: (956) 440-2817
The NPI 1184620247 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.
The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.
- Injection, denosumab, 1 mg (HCPCS:J0897)
- Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
- Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
- Injection, ceftriaxone sodium, per 250 mg (HCPCS:J0696)
- Annual alcohol misuse screening, 15 minutes (HCPCS:G0442)
- Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit (HCPCS:G0439)
- Injection of drug or substance under skin or into muscle (HCPCS:96372)
- Annual depression screening, 15 minutes (HCPCS:G0444)
- Administration of influenza virus vaccine (HCPCS:G0008)
- Influenza vaccine split virus, preservative free (HCPCS:90662)
- Injection, ketorolac tromethamine, per 15 mg (HCPCS:J1885)
- Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
- Established patient home visit, typically 40 minutes (HCPCS:99349)
- Creatinine level to test for kidney function or muscle injury (HCPCS:82570)
- Dxa bone density measurement of hip, pelvis, spine (HCPCS:77080)
- Telephone medical discussion with physician, 5-10 minutes (HCPCS:99441)
- Injection, methylprednisolone sodium succinate, up to 125 mg (HCPCS:J2930)
- Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
- Urine microalbumin (protein) analysis (HCPCS:82044)
- Automated urinalysis test (HCPCS:81003)
- Transitional care management services for problem of high complexity (HCPCS:99496)
- Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus (HCPCS:87426)
- Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report (HCPCS:93000)
- Advance care planning, first 30 minutes (HCPCS:99497)
- Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit (HCPCS:G0438)
- Insertion of needle into vein for collection of blood sample (HCPCS:36415)
- Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
- Removal of impacted ear wax by washing (HCPCS:69209)
- Hospital discharge day management, 30 minutes or less (HCPCS:99238)
- Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg (HCPCS:J7613)
- Inhalation treatment for airway obstruction or sputum production (HCPCS:94640)
- Detection test by immunoassay technique for influenza virus (HCPCS:87400)
- Influenza vaccine, quadrivalent derived from recombinant dna (HCPCS:90682)
- Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
- Hospital observation care on day of discharge (HCPCS:99217)
- Initial hospital observation care per day, typically 70 minutes (HCPCS:99220)
- Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment (HCPCS:G0402)
- New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
- Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) (HCPCS:87880)
- Hemoglobin a1c level (HCPCS:83036)
- Administration of pneumococcal vaccine (HCPCS:G0009)
- Telephone medical discussion with physician, 11-20 minutes (HCPCS:99442)
- New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
The enumeration date for this NPI number is 6/23/2005 and was last updated on 2/26/2025.
Taxonomy Codes
The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:
| No. |
Taxonomy Code |
Taxonomy Clasification |
Taxonomy Specialization |
License Number |
License State |
Primary |
| 1 | 207R00000X | Internal Medicine | | K1534 | TEXAS | Yes |
Other Identifiers
The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.
| No. |
Other Provider Identifier |
Other Provider Identifier Type |
Other Provider Identifier State |
Other Provider Identifier Issuer |
| 1 | 127487006 | MEDICAID | TEXAS | |
| 2 | K1534 | OTHER | TEXAS | STATE LICENSE |
